Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
NCT Number: NCT00416000
It has been estimated that 80% of deaths from abdominal aortic aneurysms results from rupture. Endovascular Aneurysm Repair (EVAR) has been applied to RAAA (Ruptured Abdominal Aortic Aneurysm) patients with reports of improvements. Despite the use of EVAR, patients have developed complications with lung and kidney function. This study will investigate certain biochemical processes that will potentially reduce these complications. Knowledge gained from this study may also be used to further research in this field through larger studies.
Looking for future studies?
Notify Me30 year–80 year
All sexes
Observational
Toronto, Ontario, M5G 2C4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
Time frame: 30 days
University Health Network, Toronto
Other
Phase 1 Study of Complement Activation Following Ruptured Abdominal Aortic Aneurysm: Combining Human Observation With Animal Experimentation to Establish a Framework for Human Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00488943
Abdominal Aortic Aneurysm, Aneurysm
San Francisco, California, United States
View Trial DetailsNCT02996396
Abdominal Aortic Aneurysm, Aneurysm
Augsburg, Germany
View Trial DetailsNCT06008613
Abdominal Aortic Aneurysm, Aneurysm
Cleveland, Ohio, United States
View Trial DetailsNCT06972095
Abdominal Aortic Aneurysm, Aneurysm
Arnhem, Netherlands
View Trial Details